- Conditions
- Tricuspid Valve Insufficiency
- Interventions
- Tricuspid Valve Repair System
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2024
- U.S. locations
- 4
- States / cities
- Los Angeles, California • Detroit, Michigan • Minneapolis, Minnesota + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–12
of 12
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Tricuspid Regurgitation
- Interventions
- Edwards PASCAL Transcatheter Valve Repair System
- Device
- Lead sponsor
- Edwards Lifesciences
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 15
- States / cities
- Los Angeles, California • Atlanta, Georgia • Chicago, Illinois + 11 more
- Conditions
- Tricuspid Regurgitation
- Interventions
- Transcatheter Tricuspid Valve Repair
- Device
- Lead sponsor
- Edwards Lifesciences
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2031
- U.S. locations
- 9
- States / cities
- Chicago, Illinois • Rochester, Minnesota • Morristown, New Jersey + 6 more
- Conditions
- Tricuspid Regurgitation
- Interventions
- Surgery or Transcatheter tricuspid valve intervention
- Procedure
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3,500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 4
- States / cities
- Rochester, Minnesota • New York, New York
- Conditions
- Tricuspid Regurgitation (TR)
- Interventions
- Tricuspid Transcatheter Edge-to-Edge Repair (TEER)
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2033
- U.S. locations
- 3
- States / cities
- La Jolla, California • Chicago, Illinois • Austin, Texas
- Conditions
- Tricuspid Regurgitation
- Interventions
- EVOQUE
- Other
- Lead sponsor
- Edwards Lifesciences
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 2,044 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2032
- U.S. locations
- 1
- States / cities
- Irvine, California
- Conditions
- Tricuspid Regurgitation, Tricuspid Regurgitation Functional
- Interventions
- Trillium™
- Device
- Lead sponsor
- Innoventric LTD
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 9
- States / cities
- Thousand Oaks, California • Detroit, Michigan • Rochester, Minnesota + 6 more
- Conditions
- Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases
- Interventions
- DUO Transcatheter Tricuspid Coaptation Valve System
- Device
- Lead sponsor
- CroiValve Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 13
- States / cities
- Phoenix, Arizona • Thousand Oaks, California • Atlanta, Georgia + 10 more
- Conditions
- Valve Disease, Aortic, Mitral Regurgitation (MR), Aortic Stenosis, Valvular Heart Disease, Tricuspid Regurgitation (TR), Aortic Regurgitation
- Interventions
- Not listed
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Tricuspid Regurgitation (TR)
- Interventions
- TTVI with LuX-Valve Plus System, TTVI with EVOQUE
- Device
- Lead sponsor
- Jenscare Innovation Inc.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 680 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2038
- U.S. locations
- 2
- States / cities
- Naples, Florida • The Bronx, New York
- Conditions
- Tricuspid Regurgitation (TR)
- Interventions
- Transcatheter Tricuspid Valve Intervention
- Device
- Lead sponsor
- Jenscare Innovation Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 3
- States / cities
- Los Angeles, California • Detroit, Michigan • New York, New York
- Conditions
- Severe Tricuspid Valve Regurgitation (Disorder)
- Interventions
- Inferior Vena Caval (IVC) Occlusion maneuver
- Procedure
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota